Risk factors and psychological impact on highly vulnerable adolescents during COVID-19 confinement
DOI:
https://doi.org/10.56294/saludcyt2022135Keywords:
Risk, Psychological Impact, Adolescents; Vulnerability, Confinement, COVID-19Abstract
Introduction: the confinement by COVID-19, caused the interruption of medical/psychological treatments with serious deterioration for the mental health of adolescents in condition of vulnerability.
Aim: to determine the influence of sociodemographic factors on the symptoms of depression, anxiety and stress in adolescents with medical/psychological treatment prior to COVID-19 confinement in the city of Riobamba, Ecuador.
Method: the research had a non-experimental, cross-sectional, descriptive, correlational, descriptive design aimed at 100 individuals aged 10 to 19 years, to whom a psychological measurement instrument was applied virtually and in person: DASS-21 Scale and a sociodemographic questionnaire that included questions on medical/psychological treatment prior to the pandemic. The descriptive and inferential analysis was performed with the SPSS statistical program to calculate Pearson's Chi-square and check the statistically significant relationships between the study variables and Odds ratio as a measure of probability of occurrence.
Results: the research revealed that confinement by COVID-19 determined greater affectation in the anxiety subscale, extremely severe and severe dimensions with 64% of the cases, moderate and mild with 36 %. The statistical analysis of correlation between the DASS-21 Scale and sociodemographic characteristics determined significant association between the subgroup of adolescents with previous treatments and anxiety.
Conclusions: The risk factors analyzed, influenced 11 % in the symptomatology identified by the DASS-21 with a probability of occurrence of 13,14 times for generating anxiety and 5,33 for depression in adolescents who interrupted medical/psychological treatments, during the pandemic health emergency
References
1. Torres A, Torres J. Climaterio y Menopausia. Rev. Fac. Med. 2018;61(2):15–25.
2. Ministerio de Sanidad SS e I. Guía de Práctica Clínica sobre el abordaje de síntomas vasomotores y vaginales asociados a la menopausia y postmenopausia. Primera. Ministerio de Sanidad SS e IA de E de T, (AETSA) S de A, editors. 2015.
3. González, María; Calvo M. La menopausia, signos y síntomas. Rev Médica Ocronos. 2021;4(1).
4. Mayo Clinic. Perimenopausia. MayoClinic. 2021. https://www.mayoclinic.org/es-es/diseases-conditions/perimenopause/symptoms-causes/syc-20354666
5. Fernández-Ramírez A, Mejía-Montilla J, Reyna-Villasmil, N, Torres-Cepeda, D, Reyna-Villasmil. E. Calcio sérico, grosor cortical del segundo metacarpiano y síntomas en la menopausia. Rev Obstet Ginecol Venez. 2022;82(2):145–51. https://doi.org/10.51288/00820204
6. Rivera Márquez MF, Molina Barreiro EM, Martínez Infante LM. Signos y síntomas de la menopausia. Jornada Investigaciones Médico Quirúrgicas, CIMEQ. 2021. https://aniversariocimeq2021.sld.cu/index.php/ac2021/Cimeq2021/paper/view/270/218
7. Turiño M, Colomé T, Fuentes E, Palmas S. Síntomas y enfermedades asociadas al climaterio y la menopausia. Medicentro Electrónica. 2019;23(2):116–24.
8. Tarrillo Á. Nivel de conocimiento sobre menopausia y la calidad de vida en mujeres adultas maduras del asentamiento humano Tupac Amaru, Ferreñafe, 2018. Universidad Señor de Sipán. Perú; 2022.
9. Muñoz Julca KM, Ordinola Ramírez CM, Herrera García YI. Calidad de vida y autoestima en mujeres en etapa de menopausia, Jazán, Perú. Rev Científica UNTRM Ciencias Soc y Humanidades. 2021;4(2):14. http://dx.doi.org/10.25127/rcsh.20214.707
10. Bravo EP, Águila NR, Benítez CAC, Rodríguez DS, Delgado AJG, Centeno AD. Factores biológicos y sociales que influyen en la salud de la mujer durante el climaterio y la menopausia. MediSur. 2019;17(5):719–27.
11. Ayala-Peralta F, Rodriguez-Herrera MA, Izaguirre-Lucano H, Ayala-Palomino R, Quiñones-Vásquez LA, Ayala-Moreno D, et al. Instrumentos utilizados para la medición de la calidad de vida relacionada con la salud durante el climaterio. Rev Peru Investig Matern Perinat. 2016 Dec 3;5(2):55–65. https://doi.org/10.33421/inmp.201666
12. Monterrosa-Castro Á, Paternina-Caicedo ÁJ, Herazo-Acevedo E, Oviedo-Acevedo HC, Campo Arias A. Utilidad de menopause rating scale (mrs) en indígenas colombianas en climaterio. Duazary. 2017;14(1):8. https://doi.org/10.21676/2389783X.1737
13. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. https://doi.org/10.1001/jama.2013.281053
14. González-Cárdenas L, Deus-Montes Y, Bayarre-Vea H, Hernández-Meléndez E. Calidad de Vida en mujeres de edad mediana. Revista Cubana de Medicina General Integral. 2019; 34(3):953.
15. Matzumura-Kasano JP, Gutiérrez-Crespo HF, Wong Mac JI, Alamo-Palomino IJ. Instrument for the evaluation of climacteric and menopause in the first level of care. Revista de la Facultad de Medicina Humana. 2020;20(4):560–7. https://doi.org/10.25176/RFMH.v20i4.3057
16. Lemos R. El embarazo y la lactancia pueden ayudar a evitar la menopausia precoz. Salud. 2020.
17. Argueta R. Evaluación de la calidad de vida relacionada al climaterio y menopausia. Rev Invest (Guadalajara). 2018;56(5):337–42. https://doi.org/10.5377/revunivo.v9i9.11395
18. Balcazar D, Badoui N. Revisión narrativa de la evidencia actual acerca de las alternativas hormonales y no hormonales en el manejo de los síntomas vasomotores y urogenitales de la menopausia. Univ Médica. 2018;60(1):61-72. https://doi.org/10.11144/javeriana.umed60-1.meno
19. López Sagastume JY. Calidad de vida, ansiedad y depresión en etapa del climaterio. Revista Ciencia Multidisciplinaria CUNORI. 2021;5(1):111–7. https://doi.org/10.36314/cunori.v5i1.157
20. López, Roselina; Chacón W. Sintomatología más frecuente en mujeres durante su climaterio mediante menopause rating scale. Rev Electrónica Psicol Iztacala. 2021;24(3):1277.
21. Palacios S, Hidalgo MJC, González SP, Manubens M, Sánchez-Borrego R. Síndrome genitourinario de la menopausia: recomendaciones de la Sociedad Española de Ginecología y Obstetricia. Prog Obstet Ginecol. 2019;62(2):141–8. https://doi.org/10.20960/j.pog.00182
22. García Chaves D, Jiménez Campos H. Envejecimiento del Sistema Urogenital y Disfunción Sexual Femenina TT. Med Leg Costa Rica. 2018;35(2):71–8.
Published
Issue
Section
License
Copyright (c) 2022 Mercy Balseca Valle, Darwin Noroña Salcedo (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
